Frontiers Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites

Frontiers Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease

Frontiers Endobolome, a New Concept for Determining the Influence of Microbiota Disrupting Chemicals (MDC) in Relation to Specific Endocrine Pathogenesis

Frontiers Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus

Dietary Fats and the Gut Microbiota: Their impacts on lipid-induced metabolic syndrome - ScienceDirect

Frontiers Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites

Frontiers The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation

Frontiers Potential roles of gut microbes in biotransformation of natural products: An overview

Frontiers Human gut microbiota in health and disease: Unveiling the relationship

Towards the characterisation of sustainable diet's gut microbiota composition and functions: A narrative review, Gut Microbiome

Frontiers Roles of Gut Microbial Metabolites in Diabetic Kidney Disease

Gut microbiota and diabetes: From correlation to causality and mechanism

Exploring the Oral-Gut Linkage: Interrelationship Between Oral and Systemic Diseases - Mucosal Immunology

Metabolic control by the microbiome, Genome Medicine

Frontiers Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation